Join
Live feed
·
PRReleasevia Quantisnow
ARCA biopharma Inc. logo

ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics

ByQuantisnow·Wall Street's wire, on your screen.
ABIO· ARCA biopharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ABIO (ARCA biopharma Inc.) and more on Quantisnow.